Huntington National Bank’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-239
Closed -$2.95K 4279
2024
Q4
$2.95K Hold
239
﹤0.01% 2159
2024
Q3
$2.72K Hold
239
﹤0.01% 2164
2024
Q2
$1.71K Hold
239
﹤0.01% 2199
2024
Q1
$1.6K Hold
239
﹤0.01% 2196
2023
Q4
$1.55K Buy
+239
New +$1.54K ﹤0.01% 2123
2023
Q3
Sell
-74
Closed -$1.03K 3922
2023
Q2
$1.03K Buy
74
+57
+335% +$972 ﹤0.01% 2164
2023
Q1
$319 Buy
+17
New +$279 ﹤0.01% 2109
2019
Q4
Sell
-715
Closed -$4K 1919
2019
Q3
$4K Hold
715
﹤0.01% 1405
2019
Q2
$4K Hold
715
﹤0.01% 1458
2019
Q1
$3K Sell
715
-12
-2% -$49 ﹤0.01% 1467
2018
Q4
$3K Buy
+727
New +$3.79K ﹤0.01% 1541

Other funds holding CDMO

Huntington National Bank's CDMO Position: Q1 2025 in Review

Huntington National Bank sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 239 shares — an estimated $2.95K sold.

Huntington National Bank first reported a position in CDMO in Q4 2018 and held it in 11 quarters. The position peaked at $4K in Q3 2019. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Huntington National Bank reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Huntington National Bank sold 239 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $2.95K.
  • Huntington National Bank first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2018 and held it in 11 quarters.
  • Huntington National Bank's Avid Bioservices, Inc. Common Stock position peaked at $4K in Q3 2019.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Huntington National Bank's 13F filing for Q1 2025, filed 14 May 2025.